Senior insider sale
Chief Financial Officer at DYNE THERAPEUTICS, INC. — senior position signals high conviction
$181.5K
9.54K shares
What this filing means
LUCERA ERICK plans to sell 9.54K shares of DYNE THERAPEUTICS, INC. valued at approximately $181.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2026ACC: 0001972481-26-000209
Officer· Chief Financial Officer
Since Feb 2026
9.54K
Shares to sell
$181.5K
Approx. market value
2.36K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
Equity Compensation
5/12/2026
2.36KTotal acquired2.36K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/12/2026 | Restricted Stock Units Equity Compensation | 2.36K | — |
| Total | 2.36K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.45K
Market value
$26.6K
5/13/2026
—Completed
Units to sell
5.73K
Market value
$106.8K
4/1/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
2.36K
Market value
$48.1K
6/25/2026
Total
Units
9.54K
Value
$181.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/13/2026 | 1.45K | $26.6K | — | Completed |
4/1/2026 | 5.73K | $106.8K | — | Completed |
| Planned — Approximate Date | ||||
6/25/2026 | 2.36K | $48.1K | Nasdaq | Planned |
| Total | 9.54K | $181.5K | ||